
    
      Previous studies have indicated that Fermented Protaetia brevitarsis seulensis powder may
      have the ability to improve liver function in adults with alcohol-induced liver disease.
      Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to
      investigate the effects of Fermented Protaetia brevitarsis seulensis powder on liver function
      in adults with alcohol-induced liver disease; the safety of the compound are also evaluate.
      The Investigators examine gamma-glutamyl transferase, alanine aminotransferase, aspartate
      aminotransferase, and other metabolic parameters at baseline, as well as after 4 and 8 weeks
      of intervention. Sixty adults were administered either 4,000 mg of Fermented Protaetia
      brevitarsis seulensis powder or a placebo each day for 8 weeks.
    
  